Submitted by Anonymous (not verified) on 4 November 2026 - 11:45
Human medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: Authorised